Category Archives: Stem Cell Research

Allosource Global Stem Cell Therapy Market Segmentation This market was divided into types, applications and regions. Continue reading →

Xconomy Boston Driven by 20 years in the military, the founder of Theradaptive hopes his firms regenerative paint technology platform can transform bone repair, spinal fusion, and sports medicine. The firm, spun out of MIT, has a computational platform it says turns recombinant proteins into material-binding variants that behave like a paint Continue reading →

Synthetic Stem Cells Market research report enhanced worldwide COVID19 Impact analysis on Market Size (Value, Production, Sales, Consumption, Revenue, and Growth Rate), Gross Margin, Industry Chain, Trends, Top Manufacturers, Development Trends, History and 6 Year Forecast. This Synthetic Stem Cells Market competitive landscapes provides details by topmost manufactures like (North Carolina State University, Zhengzhou University) with data such as Company Profiles, Trade Sales Volume, Gross, Cost, Industry Share By Type, Product Revenue , Specifications and Contact Information. Continue reading →

By Stephanie Chow | March 12, 2020 Three Faculty of Medicine researchers Drs. Zachary Laksman, Bruce Verchere and Tim Kieffer have collectively received more than $1.6M from the Stem Cell Network (SCN) to advance their work in stem cell and regenerative medicine research. Continue reading →

Newswise The National Institute on Aging (NIA) has extended its biobanking contract with the Coriell Institute for Medical Research for an additional five years. The newly awarded $8.6 million funding keeps Coriell in place as the trusted steward of this collection and includes the addition of new innovative products to expand the collection Continue reading →

The hunt for the elixir of life is such a universal mythological trope that to talk about it in the context of science seems almost ridiculous. But breakthroughs in the last decade have made the impossible seem possible, and researchers are quickly converging on the consensus that aging may well be a disease that we can treat just as easily as any other Continue reading →

Final results of the phase 3 CASPIAN trial show that Imfinzi (durvalumab) in combination with a choice of standard-of-care chemotherapies demonstrates a sustained overall survival benefit in patients with extensive-stage small cell lung cancer. We are pleased to see the sustained and meaningful survival benefit of Imfinzi for patients with small cell lung cancer after more than two years median follow up, Jose Baselga, executive vice president of oncology research and development at AstraZeneca, said in a company-issued press release. Continue reading →

Canine Stem Cell Therapy Market Segmentation The Canine Stem Cell Therapy Market is an intrinsic study of the current status of this business vertical and encompasses a brief synopsis about its segmentation. The report is inclusive of a nearly accurate prediction of the market scenario over the forecast period market size with respect to valuation as sales volume Continue reading →

For their study, Terzic and colleagues analyzed the hearts of mice that received cardiopoietic stem cell therapy as well as those that did not. They used an algorithmic approach to map the proteins in the heart muscle, identifying 4,000 proteins. Ten percent of these were damaged during a heart attack. Continue reading →

BEIJING: China has completed the clinical research of Favipiravir, an antiviral drug that has shown good clinical efficacy against the Covid-19 (coronavirus) outbreak, according to an official on Tuesday (March 17). Favipiravir, the influenza drug which was approved for clinical use in Japan in 2014, has shown no obvious adverse reactions in the clinical trial, said Zhang Xinmin, director of the China National Center for Biotechnology Development under the Ministry of Science and Technology, at a press conference. Continue reading →